Geraldine Henwood, Director at MAP Pharmaceuticals, Inc. (MAPP), sold 16,250 shares at $8.77 ($143K) on 2009-11-18, disclosed to the SEC on 2009-11-19.
Open-market sale of $143k MAPP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BXRX | BUY | 2021-05-10 | $5K | — | Filing → |
| REPH | SELL | 2020-04-20 | $658K | — | Filing → |
| REPH | SELL | 2019-05-15 | $1.5M | — | Filing → |